MM-134 Comparable Toxicity and Outcomes With Generic and Innovator Melphalan in Myeloma Auto Transplants

Anup Joseph Devasia,Aswin Anand Pai,Mithun Abraham Prakash,Kavita M Lakshmi,Anu Korula,Uday Kulkarni,Fouzia N Aboobacker,Sharon Lionel,Sushil Selvarajan,Aby Abraham,Alok Srivastava,Vikram Mathews,Poonkuzhali Balasubramanian,Biju George

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 0|浏览0

暂无评分

摘要

Generic MEL is comparable to innovator MEL with respect to toxicity and long-term outcomes. It is an excellent alternative for the innovator to cut the cost of transplantation in developing countries.

查看译文

关键词

MM,generic,melphalan,innovator,myeloma,outcomes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要